DUESSELDORF, Germany, July 13, 2011 /PRNewswire/ —
- Group revenues grow by 7.6 percent at constant exchange
rates in the second quarter of 2011
- Adjusted EBITDA margin is 19.8 percent
- Net income increases to EUR 13.3m
- Successful conclusion of refinancing
Gerresheimer AG, one of the leading global suppliers to the
pharma and healthcare industry, has closed successfully the second
quarter of the 2011 financial year. “We have achieved
strong growth in revenues and net income. Our Moulded Glass and
Plastic Systems Divisions have performed particularly well.
We have also strengthened our operations in South America, a
strategically important market for us, through our acquisition of
Vedat,“ said Uwe Röhrhoff, CEO of Gerresheimer
Gerresheimer was able to achieve marked growth in revenues in
the second quarter of the 2011 financial year (March 1, 2011 to
May 31, 2011) of 5.9 percent to EUR
284.5m. At constant exchange rates, revenue growth was 7.6 percent.
The Moulded Glass and Plastics Systems Divisions played an
important role in generating this strong growth. Growth drivers of
the Plastic Systems division included inhalers, insulin pens,
diagnostic systems and plastic packaging products. Vedat, the
company that Gerresheimer acquired in March, has an excellent
position in the South American primary pharmaceutical plastic
packaging market and has contributed to the positive development.
Gerresheimer recently announced plans to extend its Czech Republic
plant, being part of the fast-growing Plastic Systems division.
Gerresheimer reports adjusted EBITDA of EUR 56.3m (prior year:
EUR 56.3m) for the second quarter of 2011. The adjusted EBITDA
margin was 19.8 percent (Q2 2010: 20.9 percent). Scheduled
overhauls of furnaces and capacity restrictio